Asia Pacific Veterinary Healthcare Market

Asia Pacific Veterinary Healthcare market by Animal Type, (Dogs, Cats, Swine, Horses, Ruminants, Poultry, and Others), Products (Diagnostics (Immunodiagnostic Tests, Molecular Diagnostics, Diagnostic Imaging, Clinical Chemistry, and Other) and Therapeutics (Vaccines, Parasiticides, Anti-infectives, Medical Feed Additives, and Others), and Region (Asia pacific) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-2704
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 3
  • No. Of Pages: 210
  • Format:
  • Pub. Date: Upcoming
  • Share:

The Asia Pacific veterinary healthcare market size is projected to expand at a high CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing pet adoption and rising animal shelters in the Asia Pacific region.


Asia Pacific Veterinary Healthcare Market

In the last decade, animal health has become a major priority for several pharmaceutical businesses. The market has increased its importance as a result of increasing animal disease outbreaks combined with large-scale industrial farming, which necessitates high-quality animal feed additives, vaccinations, and hygiene management solutions.

The veterinary therapeutic market has grown in recent years as people have become more aware of the importance of veterinary medicine.

Due to increased demand for livestock, animal immunization to ensure the safety of food and dairy products, livestock animals accounted for a large share of the market.

In August 2018, China, the world's major producer and consumer of pork, reported a massive epidemic of African swine flu that killed millions of pigs. Eradication of the illness is a huge issue due to a lack of effective vaccinations and treatments, as well as good sanitary and hygiene practices.

India has a large livestock population, and animals in general play a vital part in the agricultural economy. According to the 2019 '20th Livestock Census. All India report: ministry of agriculture, department of animal husbandry, dairying & fisheries India has a population of 198.48 million cattle.

Market Trends, Drivers, Restraints, and Opportunities

  • Rising meat and milk consumption is anticipated to boost the market during the forecast period.
  • Increasing food & water borne diseases are key drivers for the market expansion.
  • Growing cases for zoonotic diseases where infections transmitted from animals to humans are major factors spurring the market growth.
  • Growing population, changing lifestyles, and high demand for quality products are projected to drive the market during the forecast period.
  • Lack of awareness is projected to hamper the market growth.

Scope of the Report

The report on the Asia-Pacific veterinary healthcare market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Asia-Pacific Veterinary Healthcare Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Animal Type, (Dogs, Cats, Swine, Horses, Ruminants, Poultry, and Others), Products (Diagnostics (Immunodiagnostic Tests, Molecular Diagnostics, Diagnostic Imaging, Clinical Chemistry, and Other) and Therapeutics (Vaccines, Parasiticides, Anti-infectives, Medical Feed Additives, and Others)

Regional Scope

Asia Pacific

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Boehringer Ingelheim International GmbH; Merck & Co., Inc; Vetoquinol; Elanco; Ceva Animal Health Inc.

Market Segment Insights

The dog’s segment is projected to account for a key market share

Based on animal types, the Asia-Pacific veterinary healthcare market is divided into dogs, cats, swine, horses, ruminants, poultry, and others. The dog’s segment is expected to represent a key share of the market during the forecast period owing to rising dog adoption for companionship and good mental health.


Asia Pacific Veterinary Healthcare Market

The vaccines segment is expected to grow at a rapid pace

On the basis of products, the Asia Pacific veterinary healthcare market is bifurcated into diagnostics and therapeutics. The therapeutics segment is further segmented into vaccines, parasiticides, anti-infectives, medical feed additives, and others. The vaccine segment is expected to represent a key share of the market due to vaccine advancements, expanding demand for animal protein, such as milk, meat, eggs, and seafood, increased government & association spending, and rising companion animal healthcare costs.


Asia Pacific Veterinary Healthcare Market

Segments

Segments Covered in the Report

The Asia Pacific veterinary healthcare market has been segmented on the basis of

Animal Type

  • Dogs
  • Cats
  • Swine
  • Horses
  • Ruminants
  • Poultry
  • Others

Products

  • Diagnostics
    • Immunodiagnostic Tests
    •  Molecular Diagnostics
    •  Diagnostic Imaging
    •  Clinical Chemistry
    •  Other
  • Therapeutics
    • Vaccines
    •  Parasiticides
    •  Anti-infectives
    • Medical Feed Additives
    • Others

Region

  • Asia Pacific

Key players

  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc
  • Vetoquinol
  • Elanco
  • Ceva Animal Health Inc.

Competitive Landscape

Key players competing in the Asia Pacific veterinary healthcare market include Boehringer Ingelheim International GmbH; Merck & Co., Inc; Vetoquinol; Elanco; Ceva Animal Health Inc.

Some of these players are using several market strategies such as acquisitions, merger, collaborations, partnerships, capacity expansion, and product launches to enhance their market. For instance,

On April 2020 Elanco Japan stated that it has gained marketing approval from the Ministry of Agriculture, Forestry, and Fisheries for the drug 'Galliprant,' which is used to treat canine osteoarthritis.

On June 2020 Vetina Healthcare LLP announced the introduction of 'Pawtect,' India's first pet medical cover for dogs.

Asia Pacific Veterinary Healthcare Market

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Veterinary Healthcare Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Veterinary Healthcare Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Veterinary Healthcare Market - Supply Chain
  4.5. Global Veterinary Healthcare Market Forecast
     4.5.1. Veterinary Healthcare Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Veterinary Healthcare Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Veterinary Healthcare Market Absolute $ Opportunity
5. Global Veterinary Healthcare Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Veterinary Healthcare Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Veterinary Healthcare Demand Share Forecast, 2019-2026
6. North America Veterinary Healthcare Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Veterinary Healthcare Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Veterinary Healthcare Demand Share Forecast, 2019-2026
7. Latin America Veterinary Healthcare Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Veterinary Healthcare Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Veterinary Healthcare Demand Share Forecast, 2019-2026
8. Europe Veterinary Healthcare Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Veterinary Healthcare Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Veterinary Healthcare Demand Share Forecast, 2019-2026
9. Asia Pacific Veterinary Healthcare Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Veterinary Healthcare Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Veterinary Healthcare Demand Share Forecast, 2019-2026
10. Middle East & Africa Veterinary Healthcare Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Veterinary Healthcare Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Veterinary Healthcare Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Veterinary Healthcare Market: Market Share Analysis
  11.2. Veterinary Healthcare Distributors and Customers
  11.3. Veterinary Healthcare Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)

Segments Covered in the Report

The Asia Pacific veterinary healthcare market has been segmented on the basis of

Animal Type

  • Dogs
  • Cats
  • Swine
  • Horses
  • Ruminants
  • Poultry
  • Others

Products

  • Diagnostics
    • Immunodiagnostic Tests
    •  Molecular Diagnostics
    •  Diagnostic Imaging
    •  Clinical Chemistry
    •  Other
  • Therapeutics
    • Vaccines
    •  Parasiticides
    •  Anti-infectives
    • Medical Feed Additives
    • Others

Region

  • Asia Pacific

Key players

  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc
  • Vetoquinol
  • Elanco
  • Ceva Animal Health Inc.

Key players competing in the Asia Pacific veterinary healthcare market include Boehringer Ingelheim International GmbH; Merck & Co., Inc; Vetoquinol; Elanco; Ceva Animal Health Inc.

Some of these players are using several market strategies such as acquisitions, merger, collaborations, partnerships, capacity expansion, and product launches to enhance their market. For instance,

On April 2020 Elanco Japan stated that it has gained marketing approval from the Ministry of Agriculture, Forestry, and Fisheries for the drug 'Galliprant,' which is used to treat canine osteoarthritis.

On June 2020 Vetina Healthcare LLP announced the introduction of 'Pawtect,' India's first pet medical cover for dogs.

Asia Pacific Veterinary Healthcare Market

Buy Report